Use of Sitagliptin to Decrease Microalbuminuria

NCT02048904 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

142

Enrollment

OTHER

Sponsor class

Stopped Original Principal Investigator left institution. No data analyzed.

Conditions

Type 2 Diabetes
Microalbuminuria

Interventions

DRUG: Sitagliptin
DRUG: Placebo

Sponsor

University of Missouri-Columbia